Clinical Trials Directory

Trials / Completed

CompletedNCT02084992

A Study of a Technology-enabled Disease Management Program to Reduce Hospitalizations for Heart Failure

A Multicenter Randomized Controlled Evaluation of Heart Failure Disease Management Using Advanced Telecommunications Within a Diverse Provider Network: The Specialized Primary and Networked Care in HF (SPAN-CHF) III Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
212 (actual)
Sponsor
Tufts Medical Center · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study will randomize participants with a diagnosis of congestive heart failure and at least one risk factor for hospitalization to either a tablet computer and web based disease management program or a telephone based disease management program. Both interventions are home based with heart failure education and symptom monitoring provided by nurse managers. The nurse managers are in close communication with both the participants and the participants' physicians . The components of the disease management program have been developed at Tufts Medical Center and the New England Quality Care Alliance with studies showing improved clinical outcomes, including reduced hospitalizations. The goal of this study is to transition this successful home monitoring and disease management program to a tablet computer and web-based implementation to both improve clinical outcomes (reducing hospitalizations and improving self-perceived health status) and improve provider-patient satisfaction. We hypothesize that the tablet computer based disease management will decrease heart failure hospitalizations.

Conditions

Interventions

TypeNameDescription
OTHERExpanded technology disease managementTablet computers loaded with a web-based disease management program will be given to patients for the duration of the study.
OTHERTelephonic disease management

Timeline

Start date
2014-06-01
Primary completion
2019-09-01
Completion
2019-09-01
First posted
2014-03-12
Last updated
2019-10-17

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT02084992. Inclusion in this directory is not an endorsement.